TruBridge, Inc. (TBRG) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $25.82 (+0.16%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
TBRG vs Sector & Market
| Metric | TBRG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | -1.5% | +1711.0% | +16.4% |
| P/E Ratio | 85.62 | 3.22 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $87M | $88M | $88M | 3 |
| 2026-09-30 | $88M | $89M | $89M | 1 |
| 2026-12-31 | $89M | $90M | $90M | 2 |
| 2027-03-31 | $91M | $92M | $92M | 1 |
| 2027-06-30 | $90M | $91M | $92M | 2 |
| 2027-09-30 | $91M | $92M | $92M | 2 |
| 2027-12-31 | $93M | $94M | $94M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.53 | $0.54 | $0.54 | 3 |
| 2026-09-30 | $0.63 | $0.64 | $0.64 | 1 |
| 2026-12-31 | $0.73 | $0.74 | $0.74 | 1 |
| 2027-03-31 | $0.72 | $0.73 | $0.74 | 1 |
| 2027-06-30 | $0.59 | $0.59 | $0.60 | 1 |
| 2027-09-30 | $0.73 | $0.74 | $0.75 | 1 |
| 2027-12-31 | $0.84 | $0.85 | $0.86 | 1 |
Frequently Asked Questions
What is the analyst consensus for TBRG?
The consensus among 3 analysts covering TruBridge, Inc. (TBRG) is Hold with an average price target of $23.00.
What is the highest price target for TBRG?
The highest analyst price target for TBRG is $23.00.
What is the lowest price target for TBRG?
The lowest analyst price target for TBRG is $23.00.
How many analysts cover TBRG?
3 analysts have issued ratings for TruBridge, Inc. in the past 12 months.
Is TBRG a buy or sell right now?
Based on 3 analyst ratings, TBRG has a consensus rating of Hold (3.00/5) with a -1.5% upside to the consensus target of $23.00.
What are the earnings estimates for TBRG?
Analysts estimate TBRG will report EPS of $0.54 for the period ending 2026-06-30, with revenue estimated at $88M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.